Buy BioTime Stock | BTX Stock Price & Latest News | Public
BTX

BioTime

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About BTX

    Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The comp...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$191,97M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$1.67
    1 Year Low$0.53
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app